Actively Recruiting
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Led by Mayo Clinic · Updated on 2025-12-24
140
Participants Needed
4
Research Sites
624 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This phase III trial studies the side effects and how well stereotactic radiosurgery (SRS) works before or after surgery in patients with tumors that has spread to the brain or that can be removed by surgery. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.
CONDITIONS
Official Title
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Confirmed or suspected solid tumor that has spread to the brain with intraparenchymal brain metastasis
- Neurosurgeon recommends surgical removal of one brain metastasis and patient is a surgical candidate
- Plan for stereotactic radiosurgery to all known brain lesions requiring treatment, with 10 or fewer metastases
- Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less
- Provide written informed consent or have a legally authorized representative provide consent
- Willing to attend follow-up visits either at the study site or with a local doctor and share clinical notes and imaging
You will not qualify if you...
- Pregnant or nursing women
- Men or women of childbearing potential unwilling to use adequate contraception
- Severe systemic illnesses or other diseases that would interfere with safety assessment
- Immunocompromised patients or HIV positive patients currently on antiretroviral therapy
- Uncontrolled illness including active infection, heart failure, unstable angina, arrhythmia, or psychiatric/social issues limiting compliance
- Prior open neurosurgery for malignancy
- Known or suspected primary germ cell tumor, small cell carcinoma, or lymphoma
- History of whole brain radiation therapy
- Allergy to gadolinium or presence of non-MRI-safe implants
- Leptomeningeal metastasis or disease
- Brain metastasis located 5 mm or less from the optic chiasm
- Any brain metastasis larger than 5 cm
- More than 10 brain metastases
- Indication for surgical removal of two or more brain metastases
- Need for long-term (over 4 weeks) high-dose steroids or bevacizumab
- Currently enrolled in another brain metastases trial involving radiation or surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
Actively Recruiting
2
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
Actively Recruiting
3
National Institutes of Neurological Disorders and Stroke, NIH
Bethesda, Maryland, United States, 20892
Actively Recruiting
4
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here